Shared on 03 Nov 25
Fair value Decreased 3.55%Analysts have revised Ashland's fair value estimate downward from $64.70 to $62.40. This revision reflects updated expectations for slightly increased revenue growth but lower profit margins, which together contribute to a modestly higher projected discount rate and future P/E multiple.
Shared on 30 Apr 25
Fair value Increased 2.13%AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 23 Apr 25
Fair value Decreased 2.93%AnalystConsensusTarget has increased revenue growth from -0.5% to -0.4%.
Shared on 17 Apr 25
Fair value Decreased 2.70%AnalystConsensusTarget has decreased revenue growth from -0.2% to -0.5%.
Shared on 09 Apr 25
Fair value Decreased 2.50%AnalystConsensusTarget has decreased revenue growth from 0.0% to -0.2%.
Shared on 02 Apr 25
Fair value Decreased 2.68%AnalystConsensusTarget has increased revenue growth from -0.0% to 0.0%.
Shared on 26 Mar 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 19 Mar 25
Fair value Decreased 2.28%AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 11 Mar 25
Fair value Increased 21%AnalystConsensusTarget has decreased revenue growth from 0.2% to -0.0%, increased profit margin from 9.9% to 15.1% and decreased future PE multiple from 23.3x to 13.2x.